Patents Assigned to BioPorto Diagnostics A/S
  • DIAGNOSTIC USE OF INDIVIDUAL MOLECULAR FORMS OF A BIOMARKER
    Publication number: 20130177923
    Abstract: Methods are provided of diagnosing, monitoring or determining the severity of disease or injury by measuring individual molecular forms of neutrophil gelatinase-associated lipocalin (NGAL) in bodily fluids, including the diagnosis and monitoring of acute renal injury leading to acute renal failure in a human or mammalian subject by determining the concentration of the free monomer form of NGAL.
    Type: Application
    Filed: February 28, 2013
    Publication date: July 11, 2013
    Applicant: BioPorto Diagnostics A/S
    Inventor: BioPorto Diagnostics A/S
  • Diagnostic test for renal injury
    Patent number: 8313919
    Abstract: A method is provided of diagnosing and monitoring acute renal injury leading to acute renal failure in a human or mammalian subject by determining the ratio of the concentration of neutrophil gelatinase-associated lipocalin (NGAL) in urine to that in plasma or serum.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: November 20, 2012
    Assignee: BioPorto Diagnostics A/S
    Inventors: Lars Otto Uttenthal, Kristian Bangert